{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:53:44Z","timestamp":1792068824061,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007120","name":"King Mongkut's Institute of Technology Ladkrabang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A650386"],"award-info":[{"award-number":["N42A650386"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118806","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:15:56Z","timestamp":1789226156000},"page":"118806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, biological and computational evaluation of Thieno[3,2-d]pyrimidine-based inhibitors of JAK3 kinase"],"prefix":"10.1016","volume":"143","author":[{"given":"Poowadon","family":"Fukasem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kittitat","family":"Jaengwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangkamol","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiattawee","family":"Choowongkomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Paul","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bmc.2026.118806_bb0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/biology11070973","article-title":"Immune-mediated diseases from the point of view of Psychoneuroimmunoendocrinology","volume":"11","author":"Ortega","year":"2022","journal-title":"Biology"},{"issue":"978","key":"10.1016\/j.bmc.2026.118806_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.bmc.2026.118806_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40348-024-00177-7","article-title":"Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers","volume":"11","author":"Kallinich","year":"2024","journal-title":"Molecular and Cellular Pediatrics"},{"key":"10.1016\/j.bmc.2026.118806_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1347402","article-title":"Inflammation as a driver of hematological malignancies","volume":"14","author":"Saluja","year":"2024","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.bmc.2026.118806_bb0025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/jcm13041019","article-title":"Prevalence and clinical impact of immune-mediated inflammatory diseases in patients with inflammatory bowel disease: results from a large retrospective observational study","volume":"13","author":"Vernero","year":"2024","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bmc.2026.118806_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020280","article-title":"JAK3 is expressed in the nucleus of malignant T cells in cutaneous T cell lymphoma (CTCL)","volume":"13","author":"Vadivel","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5646","key":"10.1016\/j.bmc.2026.118806_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"Changelian","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bmc.2026.118806_bb0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bmc.2026.118806_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.73","article-title":"Effect of NS-018, a selective JAK2V617F inhibitor, in a murine model of myelofibrosis","volume":"4","author":"Nakaya","year":"2014","journal-title":"Blood Cancer Journal"},{"key":"10.1016\/j.bmc.2026.118806_bb0050","series-title":"Clinical Immunology","first-page":"127","article-title":"Cytokines and Cytokine Receptors","author":"O'Shea","year":"2019"},{"issue":"5","key":"10.1016\/j.bmc.2026.118806_bb0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1021\/acs.jmedchem.6b01694","article-title":"Design of a Janus Kinase 3 (JAK3) specific inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 Signaling in humans","volume":"60","author":"Thorarensen","year":"2017","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2026.118806_bb0060","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1021\/acs.jmedchem.5b00710","article-title":"Development of selective covalent Janus kinase 3 inhibitors","volume":"58","author":"Tan","year":"2015","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118806_bb0065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.rcreue.2018.08.002","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in patients from Colombia with rheumatoid arthritis: pooled efficacy and safety analyses of data from phase III studies","volume":"25","author":"V\u00e9lez","year":"2018","journal-title":"Revista Colombiana de Reumatolog\u00eda (English Edition)"},{"issue":"12","key":"10.1016\/j.bmc.2026.118806_bb0070","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/acschembio.6b00677","article-title":"Discovery of a JAK3-selective inhibitor: functional differentiation of JAK3-selective inhibition over pan-JAK or JAK1-selective inhibition","volume":"11","author":"Telliez","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"4","key":"10.1016\/j.bmc.2026.118806_bb0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2008.02.009","article-title":"Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced Polycythemia Vera","volume":"13","author":"Wernig","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bmc.2026.118806_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-016-0268-z","article-title":"Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancer","volume":"9","author":"Wang","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bmc.2026.118806_bb0085","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1021\/ci900022h","article-title":"QM\/MM as a tool in fragment based drug discovery. A cross-docking, rescoring study of kinase inhibitors","volume":"49","author":"Gleeson","year":"2009","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2026.118806_bb0090","unstructured":"GOLD5.3: https:\/\/www.ccdc.cam.ac.uk\/solutions\/csd-discovery\/components\/gold\/."},{"key":"10.1016\/j.bmc.2026.118806_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"3","key":"10.1016\/j.bmc.2026.118806_bb0100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.bmc.2026.118806_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010056","article-title":"Evaluating molecular mechanical potentials for helical peptides and proteins","volume":"5","author":"Thompson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118806_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.bmc.2026.118806_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J Mol Graph Model"},{"issue":"9","key":"10.1016\/j.bmc.2026.118806_bb0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118806_bb0125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"10.1016\/j.bmc.2026.118806_bb0130","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J Chem Theory Comput"},{"issue":"20","key":"10.1016\/j.bmc.2026.118806_bb0135","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2026.118806_bb0140","series-title":"Gaussian 16, Revision C.01","author":"Frisch","year":"2016"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2026.118806_bb0145","first-page":"215","volume":"120","author":"Zhao","year":"2007","journal-title":"Theor Chem Accounts"},{"issue":"12","key":"10.1016\/j.bmc.2026.118806_bb0150","doi-asserted-by":"crossref","DOI":"10.1063\/1.2982923","article-title":"Good performance of the M06 family of hybrid meta generalized gradient approximation density functionals on a difficult case: CO adsorption on MgO(001)","volume":"129","author":"Valero","year":"2008","journal-title":"J Chem Phys"},{"key":"10.1016\/j.bmc.2026.118806_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-0716-0282-9_19","article-title":"Design and SAR analysis of covalent inhibitors driven by hybrid QM\/MM simulations","volume":"2114","author":"Lodola","year":"2020","journal-title":"Methods Mol Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:34:42Z","timestamp":1792067682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S0968089626002622"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118806","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, biological and computational evaluation of Thieno[3,2-d]pyrimidine-based inhibitors of JAK3 kinase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118806"}}